U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
The Parent Company was added by ICIJ.
The parent company information is based on 2017 public records.
데이터 추가 비고
Pump, infusion, insulin, to be used with invasive glucose sensor - Product Code OYC
원인
Medtronic is recalling the medtronic paradigm insulin pump because the pump's drive support cap may become detached from the pump case and protrude from the lower right side of the pump. when the pump is expose to water it may result in damage to the pump's internal electronics. this moisture damage can prevent the pump's buttons from working properly or can cause the pump to alarm.
조치
Medtronic sent an Urgent Medical Device Safety Notification letters to all affected customers. The recall letter informs the customers of the problem identified and the actions to be taken. The letter informs the healthcare professionals that Medtronic will inform their patients about the potential safety issues. Customers are instructed to find online information at www.medtronicdiabetes.com/support/product-updates. Customers are instructed to call Medtronic at 1.888.204.7616 (option 1 for loose drive support cap related questions and option 2 for water damage related questions). Distributors are instructed to provide Medtronic with an Excel spreadsheet list of all end users to whom they have shipped any of the listed serialized products.